Palantir is gaining significant traction in the tech world with its AI-driven services, experiencing a dramatic stock ...
Contentious hearings to consider Robert F. Kennedy Jr. to lead the Department of Health and Human Services this week have ...
Merck & Co. (MRK) stock lost over 9% yesterday on announcing a temporary shipment halt of its Gardasil vaccine to China. The ...
8don MSN
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV ...
11don MSNOpinion
President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...
The increase is driven by growth in oncology and cardiovascular, partially offset by declines in diabetes, vaccines, immunology, and virology. Merck's blockbuster cancer immunotherapy Keytruda ...
Merck's Gardasil vaccine sales over the quarters Still, sales of Keytruda, the world's top-selling prescription medicine, more than offset that shortfall. The company sold over $7.8 billion worth ...
Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results